HU9500171D0 - Tetracyclic compounds process and intermediated for their preparation and their use as antitumour agents - Google Patents

Tetracyclic compounds process and intermediated for their preparation and their use as antitumour agents

Info

Publication number
HU9500171D0
HU9500171D0 HU9500171A HU9500171A HU9500171D0 HU 9500171 D0 HU9500171 D0 HU 9500171D0 HU 9500171 A HU9500171 A HU 9500171A HU 9500171 A HU9500171 A HU 9500171A HU 9500171 D0 HU9500171 D0 HU 9500171D0
Authority
HU
Hungary
Prior art keywords
intermediated
preparation
tetracyclic compounds
antitumour agents
compounds process
Prior art date
Application number
HU9500171A
Other languages
Hungarian (hu)
Other versions
HUT76787A (en
Inventor
Karl Witold Franzmann
Jeremy Nigel Stables
Patrick Vivian Richard Shannon
Nagarja Kodanda Ranganatha Rao
Laddawan Chunchatprasert
Original Assignee
Wellcome Found
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Univ Cardiff filed Critical Wellcome Found
Publication of HU9500171D0 publication Critical patent/HU9500171D0/en
Publication of HUT76787A publication Critical patent/HUT76787A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9500171A 1992-07-20 1993-07-19 Pyrrole ring containing tetracyclic compounds, process for their preparation and pharmaceutical compositions containing them HUT76787A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215361A GB9215361D0 (en) 1992-07-20 1992-07-20 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
HU9500171D0 true HU9500171D0 (en) 1995-03-28
HUT76787A HUT76787A (en) 1997-11-28

Family

ID=10718981

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9500171A HUT76787A (en) 1992-07-20 1993-07-19 Pyrrole ring containing tetracyclic compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
EP (1) EP0651750A1 (en)
JP (1) JPH08502037A (en)
KR (1) KR950702563A (en)
CN (1) CN1088209A (en)
AU (1) AU4579593A (en)
BG (1) BG99359A (en)
CA (1) CA2140662A1 (en)
CZ (1) CZ14995A3 (en)
FI (1) FI950229A (en)
GB (1) GB9215361D0 (en)
HR (1) HRP931066A2 (en)
HU (1) HUT76787A (en)
IL (1) IL106385A0 (en)
MX (1) MX9304355A (en)
NO (1) NO950202L (en)
NZ (1) NZ254207A (en)
PL (1) PL307169A1 (en)
RU (1) RU95104939A (en)
SI (1) SI9300390A (en)
SK (1) SK7595A3 (en)
WO (1) WO1994002483A1 (en)
YU (1) YU50293A (en)
ZA (1) ZA935213B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401921D0 (en) * 1994-02-01 1994-03-30 Wellcome Found Heterocyclic compounds
GB9413758D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Heterocyclic compounds
GB9804343D0 (en) * 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
CA2437579C (en) * 2001-02-14 2012-05-01 Hector F. Deluca Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
US7419992B2 (en) 2001-02-14 2008-09-02 Wisconsin Alumni Research Foundation Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2008051523A2 (en) * 2006-10-23 2008-05-02 Georgetown University Carbazole derivatives useful as medicaments in cancer therapy
WO2010019271A1 (en) 2008-08-15 2010-02-18 Georgetown University Fluorescent regulators of rassf1a expression and human cancer cell proliferation
JP2012051804A (en) * 2008-12-26 2012-03-15 Kyoto Univ Eg5 INHIBITOR
KR20160066490A (en) * 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 Heterocyclic derivatives and use thereof
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
CN109776550B (en) * 2019-01-17 2021-08-10 广东轻工职业技术学院 Alkaloid compound derived from marine fungi and application thereof in preparation of food preservative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300688A1 (en) * 1987-07-21 1989-01-25 FISONS plc Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
US5166204A (en) * 1989-11-01 1992-11-24 Toyama Chemical Co., Ltd. Isoindole derivatives and salts thereof and antitumor agent comprising the same
JPH06503549A (en) * 1990-03-20 1994-04-21 ザ ウェルカム ファウンデーション リミテッド Biocidal heteropolycyclic compounds and their use in medicine

Also Published As

Publication number Publication date
CZ14995A3 (en) 1995-10-18
FI950229A (en) 1995-03-10
GB9215361D0 (en) 1992-09-02
HUT76787A (en) 1997-11-28
FI950229A0 (en) 1995-01-19
CA2140662A1 (en) 1994-02-03
EP0651750A1 (en) 1995-05-10
NZ254207A (en) 1997-03-24
SI9300390A (en) 1994-03-31
JPH08502037A (en) 1996-03-05
KR950702563A (en) 1995-07-29
IL106385A0 (en) 1993-11-15
NO950202D0 (en) 1995-01-19
MX9304355A (en) 1994-04-29
PL307169A1 (en) 1995-05-15
YU50293A (en) 1997-01-08
SK7595A3 (en) 1995-07-11
HRP931066A2 (en) 1995-12-31
CN1088209A (en) 1994-06-22
RU95104939A (en) 1996-10-27
NO950202L (en) 1995-01-19
ZA935213B (en) 1995-01-19
AU4579593A (en) 1994-02-14
BG99359A (en) 1995-11-30
WO1994002483A1 (en) 1994-02-03

Similar Documents

Publication Publication Date Title
IL97313A0 (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
EP0582201A3 (en) Process for the preparation of glycerincarbonate
HU9303601D0 (en) Imidazopyridine
EP0446340A4 (en) Use of liposomes as carriers for metalloporphyrins
HK1003245A1 (en) Process for the preparation of potassium clavulanate
ZA944807B (en) Novel indoline derivatives processes for their preparation and their use as cns agents
HU9500171D0 (en) Tetracyclic compounds process and intermediated for their preparation and their use as antitumour agents
ZA936197B (en) Tri-and tetracyclic compounds
EP0560109A3 (en) Process for the preparation of 1-fluorocyclopropyl-methyl-ketone
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
EP0573874A3 (en) Process for the preparation of beta-naphthylbenzylether
IL102025A0 (en) Tetracyclic antibiotics and processes for their preparation
IL99513A0 (en) Process for the preparation of carbapenem compounds
AU2805295A (en) Tetracyclic derivatives and their use as antitumour agents
GB9320940D0 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents
IL106158A0 (en) Polycyclic compounds
EP0582146A3 (en) Process for the preparation of imidazopyridines
ZA939155B (en) Substituted N-hydroxycinnamamides processes for their preparation compositions containing them and their use
ZA934107B (en) Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation
GB9008237D0 (en) Bicyclic aminohydroxamates as neuroprotective agents
HK1013293A1 (en) Process for the preparation of methylchlorosilane
IL104756A0 (en) Composition for the treatment of glaucoma
EP0550871A3 (en) Process for the preparation of cycloalcanols
GB9320769D0 (en) Tricyclic compounds
GB2273500B (en) Mitosene antitumour agents

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee